Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06200740 · ClinicalTrials.gov registry record · NA

Remotely Observed Methadone Evaluation

A NA study, sponsored by Sonara Health.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT06200740 is a NA study that has completed, run by Sonara Health. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06200740, a NA study, has completed, sponsored by Sonara Health.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

Opioid addiction, which affects 16 million individuals worldwide, can be treated using methadone, a proven and effective opioid medication for treating OUD that extends retention in care, reduces mortality, and inhibits illicit drug use. However, methadone treatment is limited to federally certified Opioid Treatment Programs (OTPs), which must meet complex regulatory requirements, and require new patients to take their dose in person six days per week, presenting significant barriers to treatment. To address these barriers, Sonara Heath has developed the Sonara software platform, which will enable OTPs to offer accelerated take-home methadone regimens while maintaining safety and diversion prevention.

Interventions

  • DEVICE Sonara

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2022-09-25
Est. Completion 2022-12-02
Phase NA

Sponsor

Sonara Health

2 total trials

What the Registry Record Tells You About NCT06200740

The ClinicalTrials.gov registry entry for NCT06200740 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sonara Health, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Sonara is the first listed.

NCT06200740 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06200740 about?

NCT06200740 is a clinical study titled "Remotely Observed Methadone Evaluation". Opioid addiction, which affects 16 million individuals worldwide, can be treated using methadone, a proven and effective opioid medication for treating OUD that extends retention in care, reduces mortality, and inhibits illicit drug use. However, methadone treatment is limited to federally certified...

What is the current status of trial NCT06200740?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2022-09-25. Estimated completion is 2022-12-02.

What interventions are being tested in trial NCT06200740?

The interventions under investigation include: Sonara (DEVICE).

Who is sponsoring clinical trial NCT06200740?

This trial is sponsored by Sonara Health, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.